Last reviewed · How we verify
DEQUALINIUM
At a glance
| Generic name | DEQUALINIUM |
|---|---|
| Drug class | dequalinium |
| Target | Protein kinase C alpha type, Small conductance calcium-activated potassium channel protein 1, Small conductance calcium-activated potassium channel protein 3 |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Dequalinium Chloride (Fluomizin) vs Oral Metronidazole for the Treatment of Bacterial Vaginosis (PHASE4)
- Treatment of BV With Donaxyl and a Molecular Test of Cure
- Comparative Efficacy Study of 10 mg Dequalinium Chloride (Fluomizin) in the Treatment of Vulvovaginal Candidiasis (PHASE4)
- Comparative Study of Efficacy of 10 mg Dequalinium Chloride (Fluomizin) in the Local Treatment of Bacterial Vaginosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |